Upgrade to SI Premium - Free Trial

Form 3 Medpace Holdings, Inc. For: Jun 01 Filed by: Hansman Brad W.

June 4, 2026 4:44 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Hansman Brad W.
(Last) (First) (Middle)
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
(Street)
CINCINNATI OH 45227
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026 		3. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Exec. VP, Operations
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 697
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) (1) Common Stock 500 (2) D
Restricted Stock Unit (3) (3) Common Stock 5,000 (2) D
Employee Stock Option (Right to Buy) (4) 04/24/2033 Common Stock 10,000 410.54 D
Explanation of Responses:
1. The restricted stock units vest in full on August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
2. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
3. The restricted stock units vest in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
4. The option vests in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Stephen P. Ewald, Attorney-in-Fact for Brad W. Hansman 06/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

EX-24

Categories

SEC Filings